Engineering, Entrepreneurship, and the Business of Modern Therapeutics: From Molecules to Cells, with a Case Study in Intelligent Cell Therapy Manufacturing Platforms

Modern therapeutics are increasingly developed not only through innovation but through the ability to engineer, scale, and sustain complex systems that must function within the real-world constraints. This seminar will examine how engineering and entrepreneurship come together to drive the development of small molecules, biologics, and advanced cell and gene therapies, with a particular focus on cell therapy.

Based on experience founding and leading several biotechnology companies across different therapeutic areas, this presentation will address the decision-making processes involved in translating technologies from early development to clinical execution. Using real-world examples, it will explore how decisions related to process development, scale-up, manufacturability, quality systems, and regulatory approaches can influence feasibility, risk, and development timelines. The presentation will illustrate how engineering decisions, made early and properly, can enable successful development programs, while delayed and misaligned decisions can constrain both development and enterprise value.

The talk will conclude with a case study of an intelligent cell therapy orchestration platform, demonstrating how systems engineering, data integration, and automation can help overcome the bottlenecks in cell therapy manufacturing and delivery. The seminar aims to share perspectives on entrepreneurship in modern therapeutics and to show how engineering principles continue to drive innovation at the intersection of biology, medicine, and business.